<VariationArchive VariationID="432012" VariationName="NM_004273.5(CHST3):c.533dup (p.Ala179fs)" VariationType="Duplication" Accession="VCV000432012" Version="28" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-15" DateCreated="2017-08-20" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="425884" VariationID="432012">
      <GeneList>
        <Gene Symbol="CHST3" FullName="carbohydrate sulfotransferase 3" GeneID="9469" HGNC_ID="HGNC:1971" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="71964395" stop="72013558" display_start="71964395" display_stop="72013558" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="73724119" stop="73773321" display_start="73724119" display_stop="73773321" Strand="+" />
          </Location>
          <OMIM>603799</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004273.5(CHST3):c.533dup (p.Ala179fs)</Name>
      <CanonicalSPDI>NC_000010.11:72007558:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="72007558" stop="72007559" display_start="72007558" display_stop="72007559" variantLength="1" positionVCF="72007558" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="73767316" stop="73767317" display_start="73767316" display_stop="73767317" variantLength="1" positionVCF="73767316" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <OtherNameList>
        <Name>CHST3</Name>
      </OtherNameList>
      <ProteinChange>A179fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.73767322dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.73767322dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.72007564dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.72007564dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012635.1" sequenceAccession="NG_012635" sequenceVersion="1" change="g.48203dup">
            <Expression>NG_012635.1:g.48203dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004273.5" sequenceAccession="NM_004273" sequenceVersion="5" change="c.533dup" MANESelect="true">
            <Expression>NM_004273.5:c.533dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004264.2" sequenceAccession="NP_004264" sequenceVersion="2" change="p.Ala179fs">
            <Expression>NP_004264.2:p.Ala179fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004273.4" sequenceAccession="NM_004273" sequenceVersion="4" change="c.533dupG">
            <Expression>NM_004273.4:c.533dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA5548112" DB="ClinGen" />
        <XRef Type="rs" ID="769540174" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004273.5(CHST3):c.533dup (p.Ala179fs) AND not provided" Accession="RCV000498884" Version="20">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2018-12-01" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004273.5(CHST3):c.533dup (p.Ala179fs) AND Spondyloepiphyseal dysplasia with congenital joint dislocations" Accession="RCV000576230" Version="4">
        <ClassifiedConditionList TraitSetID="6350">
          <ClassifiedCondition DB="MedGen" ID="C1837657">Spondyloepiphyseal dysplasia with congenital joint dislocations</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-23" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-08-20" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20830804</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27753269</ID>
        </Citation>
        <DescriptionHistory Dated="2018-01-04">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="6350" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1661" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Humero-spinal dysostosis with congenital heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Kozlowski Celermajer Tink syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Spondyloepiphyseal dysplasia with congenital joint dislocations</ElementValue>
                <XRef ID="Spondyloepiphyseal+dysplasia+Omani+type/6824" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007738" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSD</ElementValue>
                <XRef Type="MIM" ID="143095" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">SEDCJD</ElementValue>
                <XRef Type="MIM" ID="143095" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2533" />
                <XRef ID="2533" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CHST3-related skeletal dysplasia is characterized by short stature of prenatal onset, joint dislocations (knees, hips, radial heads), clubfeet, and limitation of range of motion that can involve all large joints. Kyphosis and occasionally scoliosis with slight shortening of the trunk develop in childhood. Minor heart valve dysplasia has been described in several persons. Intellect and vision are normal.</Attribute>
                <XRef ID="NBK62112" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13169" />
                <XRef ID="13169" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21882400</ID>
                <ID Source="BookShelf">NBK62112</ID>
              </Citation>
              <XRef ID="263463" DB="Orphanet" />
              <XRef ID="C1837657" DB="MedGen" />
              <XRef ID="MONDO:0007738" DB="MONDO" />
              <XRef Type="MIM" ID="143095" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1328108" SubmissionDate="2017-12-19" DateLastUpdated="2018-01-06" DateCreated="2018-01-06">
        <ClinVarSubmissionID localKey="SUB3348442" submittedAssembly="GRCh37" title="SUB3348442" />
        <ClinVarAccession Accession="SCV000622095" DateUpdated="2018-01-06" DateCreated="2018-01-06" Type="SCV" Version="1" SubmitterName="Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences" OrgID="505943" OrganizationCategory="other" OrgAbbreviation="SGPGIMS" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This mutation leads to frameshift mutation (p.A179R fs*141) and was found to be pathogenic by in silico tools. Parents were found to be heterozygous carriers.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Ethnicity>Indian</Ethnicity>
              <GeographicOrigin>India</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>ABI310</NamePlatform>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Description>The two coding exons of CHST3 were amplified by PCR and cycle sequenced using the ABI Prism BigDye Terminator Cycle Sequencing Ready Reaction Kit Version 1.1 (Applied Biosystems, Darmstadt, Germany). Capillary electrophoresis was performed using an ABI 310 sequencer (Applied Biosystems, Foster City, CA).</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0003071" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0010049" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="Human Phenotype Ontology" ID="HP:0003093" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004273.4:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">S112</Name>
            <Name>CHST3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004273.4:c.533dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143095" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">27753269</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB3348442</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1143318" SubmissionDate="2019-01-29" DateLastUpdated="2017-08-20" DateCreated="2017-08-20">
        <ClinVarSubmissionID localKey="GDX:753046|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000589674" DateUpdated="2017-08-20" DateCreated="2017-08-20" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The c.533dupG variant in the CHST3 gene has been reported previously in the homozygous state, using alternate nomenclature of c.533_534insG, in two unrelated Arab individuals affected with carbohydrate sulfotransferase 3 deficiency, congenital joint dislocations, and short stature (Unger et al., 2010). The same homozygous variant was also reported in a child of Indian descent with extreme short stature, joint contractures and prominence, and vertebral abnormalities (Srivastava et al., 2017). The c.533dupG variant causes a frameshift starting with codon Alanine 179, changes this amino acid to am Arginine residue, and creates a premature Stop codon at position 141 of the new reading frame, denoted p.Ala179ArgfsX141. This variant is predicted to cause loss of normal protein function through protein truncation. The c.533dupG variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.533dupG as a likely pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHST3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="GG" referenceAllele="G" start="73767322" stop="73767323" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004273.4:c.533dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2468144" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101440|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001246552" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHST3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="10" alternateAllele="CG" referenceAllele="C" start="73767316" stop="73767316" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7512301" SubmissionDate="2023-07-18" DateLastUpdated="2023-07-22" DateCreated="2023-07-22">
        <ClinVarSubmissionID localKey="10-73767316-C-CG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004013483" DateUpdated="2023-07-22" DateCreated="2023-07-22" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.003%). The variant is predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000432012). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002655" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHST3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004273.5:c.533dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="143095" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13689199</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7980557" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4885700|MedGen:C1840471" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004294751" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20830804</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27753269</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the CHST3 protein in which other variant(s) (p.Leu286Trpfs*48) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 432012). This premature translational stop signal has been observed in individuals with CHST3-related conditions (PMID: 20830804, 27753269; Invitae). This variant is present in population databases (rs774572727, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Ala179Argfs*141) in the CHST3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 301 amino acid(s) of the CHST3 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHST3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.73767316_73767317insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1840471" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1328108" TraitType="Finding" MappingType="XRef" MappingValue="HP:0010049" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C1837084" Name="Short metacarpal" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512301" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002655" MappingRef="HP">
        <MedGen CUI="C0038015" Name="Spondyloepiphyseal dysplasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1143318" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1328108" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003071" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C1857527" Name="Flattened epiphysis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2468144" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7980557" TraitType="Disease" MappingType="XRef" MappingValue="C1840471" MappingRef="MedGen">
        <MedGen CUI="C1837657" Name="Spondyloepiphyseal dysplasia with congenital joint dislocations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1328108" TraitType="Disease" MappingType="XRef" MappingValue="143095" MappingRef="OMIM">
        <MedGen CUI="C1837657" Name="Spondyloepiphyseal dysplasia with congenital joint dislocations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7512301" TraitType="Disease" MappingType="XRef" MappingValue="143095" MappingRef="OMIM">
        <MedGen CUI="C1837657" Name="Spondyloepiphyseal dysplasia with congenital joint dislocations" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1328108" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003093" MappingRef="Human Phenotype Ontology">
        <MedGen CUI="C3553368" Name="Limited hip extension" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

